Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5730)
All Articles published online
|
Mar 28, 2010 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fan LL, Sun GP, Wei W, Wang ZG, Ge L, Fu WZ, Wang H. Melatonin and Doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines. World J Gastroenterol 2010; 16(12): 1473-1481 [PMID: 20333787 DOI: 10.3748/wjg.v16.i12.1473] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i12/1473.htm |
| Number | Citing Articles |
| 1 |
Francesca Capone, Eliana Guerriero, Angela Sorice, Giovanni Colonna, Gabriella Storti, Jessica Pagliuca, Giuseppe Castello, Susan Costantini. Synergistic Antitumor Effect of Doxorubicin and Tacrolimus (FK506) on Hepatocellular Carcinoma Cell Lines. The Scientific World Journal 2014; 2014: 1 doi: 10.1155/2014/450390
|
| 2 |
Néstor Prieto‐Domínguez, Raquel Ordóñez, Anna Fernández, Carolina Méndez‐Blanco, Anna Baulies, Carmen Garcia‐Ruiz, José C. Fernández‐Checa, José L. Mauriz, Javier González‐Gallego. Melatonin‐induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy. Journal of Pineal Research 2016; 61(3): 396 doi: 10.1111/jpi.12358
|
| 3 |
Jiao-Jiao Zhang, Xiao Meng, Ya Li, Yue Zhou, Dong-Ping Xu, Sha Li, Hua-Bin Li. Effects of Melatonin on Liver Injuries and Diseases. International Journal of Molecular Sciences 2017; 18(4): 673 doi: 10.3390/ijms18040673
|
| 4 |
Quynh Hoa Tran, Dang Hieu Hoang, Minhyeok Song, Wonchae Choe, Insug Kang, Sung Soo Kim, Joohun Ha. Melatonin and doxorubicin synergistically enhance apoptosis via autophagy-dependent reduction of AMPKα1 transcription in human breast cancer cells. Experimental & Molecular Medicine 2021; 53(9): 1413 doi: 10.1038/s12276-021-00675-y
|
| 5 |
Andrea Janz Moreira, Raquel Ordoñez, Carlos Thadeu Cerski, Jaqueline Nascimento Picada, Andrés García-Palomo, Norma Possa Marroni, Jose L. Mauriz, Javier González-Gallego, Matias A Avila. Melatonin Activates Endoplasmic Reticulum Stress and Apoptosis in Rats with Diethylnitrosamine-Induced Hepatocarcinogenesis. PLOS ONE 2015; 10(12): e0144517 doi: 10.1371/journal.pone.0144517
|
| 6 |
Sebastian Buschauer, Andreas Koch, Philipp Wiggermann, Martina M�ller, Claus Hellerbrand. Hepatocellular carcinoma cells surviving doxorubicin treatment exhibit increased migratory potential and resistance to doxorubicin re-treatment in�vitro. Oncology Letters 2018; doi: 10.3892/ol.2018.7887
|
| 7 |
Yu Bin Ji, Fang Dong, Shi Yong Gao, Miao Yu. Study on <i>Capparis spionosa L.</i> Polysaccharide (CSPS) Induced HepG2 Apoptosis by Controlling Ca<sup>2</sup><sup>+</sup> Path. Advanced Materials Research 2011; : 203 doi: 10.4028/www.scientific.net/AMR.282-283.203
|
| 8 |
Walaa M. Elwan, Amira A. Kassab, Marwa A.A. Ibrahim. The possible role of berberine in ameliorating doxorubicin- induced cardiomyopathy in adult male albino rat. The Egyptian Journal of Histology 2016; 39(3): 228 doi: 10.1097/01.EHX.0000490001.63817.c1
|
| 9 |
P. Plaimee, N. Weerapreeyakul, S. Barusrux, N. P. Johns. Melatonin potentiates cisplatin‐induced apoptosis and cell cycle arrest in human lung adenocarcinoma cells. Cell Proliferation 2015; 48(1): 67 doi: 10.1111/cpr.12158
|
| 10 |
Steven M Hill, Victoria P Belancio, Robert T Dauchy, Shulin Xiang, Samantha Brimer, Lulu Mao, Adam Hauch, Peter W Lundberg, Whitney Summers, Lin Yuan, Tripp Frasch, David E Blask. Melatonin: an inhibitor of breast cancer. Endocrine-Related Cancer 2015; 22(3): R183 doi: 10.1530/ERC-15-0030
|
| 11 |
Hassan Ghasemi, Ali Jamshidi, Mohammad Amin Ghatee, Komeil Mazhab-Jafari, Milad Khorasani, Mina Rahmati, Saeed Mohammadi. PPARγ activation by pioglitazone enhances the anti-proliferative effects of doxorubicin on pro-monocytic THP-1 leukemia cells via inducing apoptosis and G2/M cell cycle arrest. Journal of Receptors and Signal Transduction 2022; 42(5): 429 doi: 10.1080/10799893.2021.1988972
|
| 12 |
Shibo Lin, Katrin Hoffmann, Chao Gao, Marius Petrulionis, Ingrid Herr, Peter Schemmer. Melatonin promotes sorafenib‐induced apoptosis through synergistic activation of JNK/c‐jun pathway in human hepatocellular carcinoma. Journal of Pineal Research 2017; 62(3) doi: 10.1111/jpi.12398
|
| 13 |
Roberto Pariente, Ignacio Bejarano, Javier Espino, Ana B. Rodríguez, José A. Pariente. Participation of MT3 melatonin receptors in the synergistic effect of melatonin on cytotoxic and apoptotic actions evoked by chemotherapeutics. Cancer Chemotherapy and Pharmacology 2017; 80(5): 985 doi: 10.1007/s00280-017-3441-3
|
| 14 |
Masomeh Maleki, Nafiseh Khelghati, Forough Alemi, Simin Younesi, Zatollah Asemi, Rozita Abolhasan, Mahtab Bazdar, Hossein Samadi‐Kafil, Bahman Yousefi. Multiple interactions between melatonin and non‐coding RNAs in cancer biology. Chemical Biology & Drug Design 2021; 98(3): 323 doi: 10.1111/cbdd.13849
|
| 15 |
Guangfeng Niu, Bahman Yousefi, Durdi Qujeq, Abdoljalal Marjani, Jahanbakhsh Asadi, Zhan Wang, Seyed Mostafa Mir. Melatonin and doxorubicin co-delivered via a functionalized graphene-dendrimeric system enhances apoptosis of osteosarcoma cells. Materials Science and Engineering: C 2021; 119: 111554 doi: 10.1016/j.msec.2020.111554
|
| 16 |
Abdulhadi C. Uguz, Bilal Cig, Javier Espino, Ignacio Bejarano, Mustafa Naziroglu, Ana B. Rodríguez, José A. Pariente. Melatonin potentiates chemotherapy‐induced cytotoxicity and apoptosis in rat pancreatic tumor cells. Journal of Pineal Research 2012; 53(1): 91 doi: 10.1111/j.1600-079X.2012.00974.x
|
| 17 |
Lena Hisham Odeh, Wamidh H. Talib, Iman A. Basheti. Synergistic effect of thymoquinone and melatonin against breast cancer implanted in mice. Journal of Cancer Research and Therapeutics 2018; 14(Suppl 2): S324 doi: 10.4103/0973-1482.235349
|
| 18 |
Bianka Bojková, Peter Kubatka, Tawar Qaradakhi, Anthony Zulli, Karol Kajo. Melatonin May Increase Anticancer Potential of Pleiotropic Drugs. International Journal of Molecular Sciences 2018; 19(12): 3910 doi: 10.3390/ijms19123910
|
| 19 |
Niloufar Targhazeh, Russel J. Reiter, Mahdi Rahimi, Durdi Qujeq, Tooba Yousefi, Mohammad Hassan Shahavi, Seyed Mostafa Mir. Oncostatic activities of melatonin: Roles in cell cycle, apoptosis, and autophagy [Biochimie 200 (2022) 44–59]. Biochimie 2022; 200: 44 doi: 10.1016/j.biochi.2022.05.008
|
| 20 |
Antonio Gonzalez, Angel del Castillo-Vaquero, Alvaro Miro-Moran, Jose A. Tapia, Gines M. Salido. Melatonin reduces pancreatic tumor cell viability by altering mitochondrial physiology. Journal of Pineal Research 2011; 50(3): 250 doi: 10.1111/j.1600-079X.2010.00834.x
|
| 21 |
Roberto Pariente, Ignacio Bejarano, Ana Beatriz Rodríguez, José Antonio Pariente, Javier Espino. Melatonin increases the effect of 5-fluorouracil-based chemotherapy in human colorectal adenocarcinoma cells in vitro. Molecular and Cellular Biochemistry 2018; 440(1-2): 43 doi: 10.1007/s11010-017-3154-2
|
| 22 |
Fabíola Carine Monteiro de Sousa, Antônio Rafael Coelho Jorge, Ramon Róseo Paula Pessoa Bezerra de Menezes, Alba Fabíola Costa Torres, Clarissa Perdigão Mello, Danya Bandeira Lima, Diva Maria Borges Nojosa, Alexandre Havt, Renata Sousa Alves, Alice Maria Costa Martins, Helena Serra Azul Monteiro. Bothrops erythromelas ( ) venom induces apoptosis on renal tubular epithelial cells. Toxicon 2016; 118: 82 doi: 10.1016/j.toxicon.2016.04.040
|
| 23 |
Shakir Saleem, Ruqaiyah Khan, Muhammad Afzal, Imran Kazmi. Oxyphenbutazone promotes cytotoxicity in rats and Hep3B cellsvia suppression of PGE2 and deactivation of Wnt/β-catenin signaling pathway. Molecular and Cellular Biochemistry 2018; 444(1-2): 187 doi: 10.1007/s11010-017-3243-2
|
| 24 |
Roberto Pariente, José A. Pariente, Ana B. Rodríguez, Javier Espino. Melatonin sensitizes human cervical cancer HeLa cells to cisplatin‐induced cytotoxicity and apoptosis: effects on oxidative stress and DNA fragmentation. Journal of Pineal Research 2016; 60(1): 55 doi: 10.1111/jpi.12288
|
| 25 |
Alireza Mafi, Malihe Rezaee, Neda Hedayati, Sara Diana Hogan, Russel J. Reiter, Mohammad-Hossein Aarabi, Zatollah Asemi. Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy. Cell Communication and Signaling 2023; 21(1) doi: 10.1186/s12964-023-01047-x
|
| 26 |
Patrik Prša, Betül Karademir, Gökhan Biçim, Hatem Mahmoud, Inbal Dahan, A. Süha Yalçın, Jamal Mahajna, Irina Milisav. The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics. Biochemical Pharmacology 2020; 173: 113551 doi: 10.1016/j.bcp.2019.06.007
|
| 27 |
Hesham Haffez, Nosaiba A. Elsayed, Marwa F. Ahmed, Samar S. Fatahala, Eman F. Khaleel, Rehab Mustafa Badi, Eslam B. Elkaeed, Mahmoud A. El Hassab, Sherif F. Hammad, Wagdy M. Eldehna, Nicolas Masurier, Radwan El-Haggar.
Novel
N
-Arylmethyl-aniline/chalcone hybrids as potential VEGFR inhibitors: synthesis, biological evaluations, and molecular dynamic simulations
. Journal of Enzyme Inhibition and Medicinal Chemistry 2023; 38(1) doi: 10.1080/14756366.2023.2278022
|
| 28 |
Wamidh H. Talib, Ahmad Riyad Alsayed, Alaa Abuawad, Safa Daoud, Asma Ismail Mahmod. Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities. Molecules 2021; 26(9): 2506 doi: 10.3390/molecules26092506
|
| 29 |
Renata Kontek, Hanna Nowicka. The modulatory effect of melatonin on genotoxicity of irinotecan in healthy human lymphocytes and cancer cells. Drug and Chemical Toxicology 2013; 36(3): 335 doi: 10.3109/01480545.2012.737805
|
| 30 |
Renata Kontek, Marta Jakubczak, Ksenia Matlawska-Wasowska. The antioxidants, vitamin A and E but not vitamin C and melatonin enhance the proapoptotic effects of irinotecan in cancer cells in vitro. Toxicology in Vitro 2014; 28(2): 282 doi: 10.1016/j.tiv.2013.11.007
|
| 31 |
Sangiliyandi Gurunathan, Min-Hee Kang, Jin-Hoi Kim. Role and Therapeutic Potential of Melatonin in the Central Nervous System and Cancers. Cancers 2020; 12(6): 1567 doi: 10.3390/cancers12061567
|
| 32 |
Zhiqiang Ma, Dong Liu, Shouyin Di, Zhipei Zhang, Weimiao Li, Jiao Zhang, Liqun Xu, Kai Guo, Yifang Zhu, Xiaofei Li, Jing Han, Xiaolong Yan. Histone deacetylase 9 downregulation decreases tumor growth and promotes apoptosis in non‐small cell lung cancer after melatonin treatment. Journal of Pineal Research 2019; 67(2) doi: 10.1111/jpi.12587
|
| 33 |
Paula Fernández-Palanca, Carolina Méndez-Blanco, Flavia Fondevila, María J. Tuñón, Russel J. Reiter, José L. Mauriz, Javier González-Gallego. Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review. Antioxidants 2021; 10(1): 103 doi: 10.3390/antiox10010103
|
| 34 |
Shahbaz Ahmad Zakki, Jibran Sualeh Muhammad, Jin-Long Li, Lu Sun, Meng-Ling Li, Qian-Wen Feng, Yu-Lin Li, Zheng-Guo Cui, Hidekuni Inadera. Melatonin triggers the anticancer potential of phenylarsine oxide via induction of apoptosis through ROS generation and JNK activation. Metallomics 2020; 12(3): 396 doi: 10.1039/c9mt00238c
|
| 35 |
Nian Zhou, Feifei Mao, Shuqun Cheng, Anisha Dsouza. Mechanism Research and Application for Ginsenosides in the Treatment of Hepatocellular Carcinoma. BioMed Research International 2023; 2023(1) doi: 10.1155/2023/7214037
|
| 36 |
I S Arif, C L Hooper, F Greco, A C Williams, S Y Boateng. Increasing doxorubicin activity against breast cancer cells using PPARγ‐ligands and by exploiting circadian rhythms. British Journal of Pharmacology 2013; 169(5): 1178 doi: 10.1111/bph.12202
|
| 37 |
Olga Krestinina, Roman Fadeev, Alexey Lomovsky, Yulia Baburina, Margarita Kobyakova, Vladimir Akatov. Melatonin Can Strengthen the Effect of Retinoic Acid in HL-60 Cells. International Journal of Molecular Sciences 2018; 19(10): 2873 doi: 10.3390/ijms19102873
|
| 38 |
Ahmed R. Hamed, Shaymaa M. M. Yahya, Heba K. Nabih. Anti-drug resistance, anti-inflammation, and anti-proliferation activities mediated by melatonin in doxorubicin-resistant hepatocellular carcinoma: in vitro investigations. Naunyn-Schmiedeberg's Archives of Pharmacology 2023; 396(6): 1117 doi: 10.1007/s00210-023-02385-w
|
| 39 |
Lucrecia Regina G. Romeu, Eduardo Leme A. da Motta, Carla C. Maganhin, Celina T.F. Oshima, Marcelle C. Fonseca, Karina F. Barrueco, Ricardo S. Simões, Renata Pellegrino, Edmund C. Baracat, José M. Soares-Junior. Effects of melatonin on histomorphology and on the expression of steroid receptors, VEGF, and PCNA in ovaries of pinealectomized female rats. Fertility and Sterility 2011; 95(4): 1379 doi: 10.1016/j.fertnstert.2010.04.042
|
| 40 |
Eun Jung Park, Seon Min Woo, Kyoung‐jin Min, Taeg Kyu Kwon. Transcriptional and post‐translational regulation of Bim controls apoptosis in melatonin‐treated human renal cancer Caki cells. Journal of Pineal Research 2014; 56(1): 97 doi: 10.1111/jpi.12102
|
| 41 |
A. Carpentieri, G. Díaz de Barboza, V. Areco, M. Peralta López, N. Tolosa de Talamoni. New perspectives in melatonin uses. Pharmacological Research 2012; 65(4): 437 doi: 10.1016/j.phrs.2012.01.003
|
| 42 |
Parisa Maleki Dana, Fatemeh Sadoughi, Russel J. Reiter, Sotoudeh Mohammadi, Zahra Heidar, Masoumeh Mirzamoradi, Zatollah Asemi. Melatonin as an adjuvant treatment modality with doxorubicin. Biochimie 2022; 202: 49 doi: 10.1016/j.biochi.2022.06.007
|
| 43 |
A. I. Lomovsky, Yu. L. Baburina, M. I. Kobyakova, R. S. Fadeev, V. S. Akatov, O. V. Krestinina. Melatonin Enhances the Chemotherapeutic Effect of Cytarabin in HL-60 Cells. Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology 2020; 14(2): 140 doi: 10.1134/S1990747819060072
|
| 44 |
Yulia Baburina, Alexey Lomovsky, Olga Krestinina. Melatonin as a Potential Multitherapeutic Agent. Journal of Personalized Medicine 2021; 11(4): 274 doi: 10.3390/jpm11040274
|
| 45 |
Fatemeh Moradkhani, Milad Moloudizargari, Marjan Fallah, Narjes Asghari, Heidar Heidari Khoei, Mohammad Hossein Asghari. Immunoregulatory role of melatonin in cancer. Journal of Cellular Physiology 2020; 235(2): 745 doi: 10.1002/jcp.29036
|
| 46 |
Xiao-liang Cheng, Tian-yan Zhou, Bo Li, Meng-yao Li, Liang Li, Zai-quan Li, Wei Lu. Methotrexate and 5-aminoimidazole-4-carboxamide riboside exert synergistic anticancer action against human breast cancer and hepatocellular carcinoma. Acta Pharmacologica Sinica 2013; 34(7): 951 doi: 10.1038/aps.2013.16
|
| 47 |
Jianliang Shen, Linwen Zeng, Liangming Pan, Shaofeng Yuan, Ming Wu, Xiongdong Kong. Tetramethylpyrazine regulates breast cancer cell viability, migration, invasion and apoptosis by affecting the activity of Akt and caspase-3. Oncology Letters 2018; doi: 10.3892/ol.2018.7851
|
| 48 |
Lina Mi, Hongyu Kuang. <p>Melatonin Regulates Cisplatin Resistance and Glucose Metabolism Through Hippo Signaling in Hepatocellular Carcinoma Cells</p>. Cancer Management and Research 2020; : 1863 doi: 10.2147/CMAR.S230466
|
| 49 |
Parisa Maleki Dana, Fatemeh Sadoughi, Russel J. Reiter, Sotoudeh Mohammadi, Zahra Heidar, Masoumeh Mirzamoradi, Zatollah Asemi. Melatonin as an adjuvant treatment modality with doxorubicin [Biochimie 200 (2022) 1–7]. Biochimie 2022; 200: 1 doi: 10.1016/j.biochi.2022.05.005
|
| 50 |
Niloufar Targhazeh, Karla J. Hutt, Amy L. Winship, Russel Reiter, Bahman Yousefi. Melatonin as an oncostatic agent: Review of the modulation of tumor microenvironment and overcoming multidrug resistance. Biochimie 2022; 202: 71 doi: 10.1016/j.biochi.2022.09.010
|
| 51 |
Aida Rodriguez‐Garcia, Juan C. Mayo, David Hevia, Isabel Quiros‐Gonzalez, Maria Navarro, Rosa M. Sainz. Phenotypic changes caused by melatonin increased sensitivity of prostate cancer cells to cytokine‐induced apoptosis. Journal of Pineal Research 2013; 54(1): 33 doi: 10.1111/j.1600-079X.2012.01017.x
|
| 52 |
Pınar Atukeren, Hafize Uzun. Melatonin, Neuroprotective Agents and Antidepressant Therapy. 2016; : 165 doi: 10.1007/978-81-322-2803-5_13
|
| 53 |
Niloufar Targhazeh, Russel J. Reiter, Mahdi Rahimi, Durdi Qujeq, Tooba Yousefi, Mohammad Hassan Shahavi, Seyed Mostafa Mir. Oncostatic activities of melatonin: Roles in cell cycle, apoptosis, and autophagy. Biochimie 2022; 202: 34 doi: 10.1016/j.biochi.2022.06.008
|
| 54 |
Ignacio Bejarano, Javier Espino, Ana M. Marchena, Carmen Barriga, Sergio D. Paredes, Ana B. Rodríguez, José A. Pariente. Melatonin enhances hydrogen peroxide-induced apoptosis in human promyelocytic leukaemia HL-60 cells. Molecular and Cellular Biochemistry 2011; 353(1-2): 167 doi: 10.1007/s11010-011-0783-8
|
| 55 |
Ko-Hsiu Lu, Chiao-Wen Lin, Yi-Hsien Hsieh, Shih-Chi Su, Russel J. Reiter, Shun-Fa Yang. New insights into antimetastatic signaling pathways of melatonin in skeletomuscular sarcoma of childhood and adolescence. Cancer and Metastasis Reviews 2020; 39(1): 303 doi: 10.1007/s10555-020-09845-2
|
| 56 |
Zi Ni Ngai, Kian Chung Chok, Khuen Yen Ng, Rhun Yian Koh, Soi Moi Chye. Potential role of melatonin in prevention and treatment of lung cancer. Hormone Molecular Biology and Clinical Investigation 2022; 43(4): 485 doi: 10.1515/hmbci-2022-0018
|
| 57 |
Lulu Fan, Guoping Sun, Tai Ma, Fei Zhong, Yu Lei, Xiaoqiu Li, Wei Wei. Melatonin reverses tunicamycin‐induced endoplasmic reticulum stress in human hepatocellular carcinoma cells and improves cytotoxic response to doxorubicin by increasing CHOP and decreasing Survivin. Journal of Pineal Research 2013; 55(2): 184 doi: 10.1111/jpi.12061
|
| 58 |
Jie Qi, Xiangyuan Chen, Qichao Wu, Jing Wang, Hao Zhang, Anrong Mao, Minmin Zhu, Changhong Miao. Fasting Induces Hepatocellular Carcinoma Cell Apoptosis by Inhibiting SET8 Expression. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/3985089
|
| 59 |
Shuang Wang, Minghui Wei, Weiyu Zhu. WITHDRAWN: Melatonin increases doxorubicin-induced apoptosis via oxidative DNA damage in oral squamous cell carcinoma. DNA Repair 2021; : 103154 doi: 10.1016/j.dnarep.2021.103154
|
| 60 |
Sun-Mi Yun, Sang Hyeok Woo, Sang Taek Oh, Sung-Eun Hong, Tae-Boo Choe, Sang-Kyu Ye, Eun-Kyu Kim, Min Ki Seong, Hyun-A Kim, Woo Chul Noh, Jin Kyung Lee, Hyeon-Ok Jin, Yun-Han Lee, In-Chul Park. Melatonin enhances arsenic trioxide-induced cell death via sustained upregulation of Redd1 expression in breast cancer cells. Molecular and Cellular Endocrinology 2016; 422: 64 doi: 10.1016/j.mce.2015.11.016
|
| 61 |
S Carbajo-Pescador, C Steinmetz, A Kashyap, S Lorenz, J L Mauriz, M Heise, P R Galle, J González-Gallego, S Strand. Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells. British Journal of Cancer 2013; 108(2): 442 doi: 10.1038/bjc.2012.563
|
| 62 |
Dilşad Özerkan, Nesrin Özsoy, Erkan Yılmaz. Vitamin D and melatonin protect the cell’s viability and ameliorate the CCl4 induced cytotoxicity in HepG2 and Hep3B hepatoma cell lines. Cytotechnology 2015; 67(6): 995 doi: 10.1007/s10616-014-9738-8
|
| 63 |
Keywan Mortezaee. Human hepatocellular carcinoma: Protection by melatonin. Journal of Cellular Physiology 2018; 233(10): 6486 doi: 10.1002/jcp.26586
|
| 64 |
Shu Li Shao, Wen Jing Sui, Shuang Li, Wei Wei Zhang, Wei Zhao, Jin Ping Song. Effects of Proliferation and Apoptosis in Human Gastric Cancer Cell Line SGC-7901 Induced by Zedoary Turmeric Oil. Advanced Materials Research 2012; 599: 67 doi: 10.4028/www.scientific.net/AMR.599.67
|
| 65 |
JUCIMARA COLOMBO, JOÃO MARCOS WOLF MACIEL, LÍVIA CARVALHO FERREIRA, RENATO FERREIRA DA SILVA, DEBORA APARECIDA PIRES ZUCCARI. Effects of melatonin on HIF-1α and VEGF expression and on the invasive properties of hepatocarcinoma cells. Oncology Letters 2016; 12(1): 231 doi: 10.3892/ol.2016.4605
|
| 66 |
Ashour A. Abdel-Mawla, Geylan A. Fadali, Eman A. Youssef, Hoda E. Eliwa. Induction of hepatocellular carcinoma in mice and the role of melatonin. The Journal of Basic & Applied Zoology 2013; 66(4): 206 doi: 10.1016/j.jobaz.2012.12.004
|
| 67 |
Ji‐Hyun Kim, Soo‐Jin Jeong, Bonglee Kim, Sun‐Mi Yun, Do Young Choi, Sung‐Hoon Kim. Melatonin synergistically enhances cisplatin‐induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK‐OV‐3 cells. Journal of Pineal Research 2012; 52(2): 244 doi: 10.1111/j.1600-079X.2011.00935.x
|
| 68 |
M. Sánchez-Hidalgo, J. M. Guerrero, I. Villegas, Catalina Alarcón De La Lastra. Natural compounds as inducers of cell death. 2012; : 127 doi: 10.1007/978-94-007-4575-9_6
|
| 69 |
Seyed Mostafa Mir, Bahman Yousefi, Abdoljalal Marjani, Mahdi Rahimi, Durdi Qujeq. The Sensitization of Melatonin in Osteosarcoma Cells by Suppression of Anti-Apoptotic Proteins. Pharmaceutical Sciences 2020; 26(2): 159 doi: 10.34172/PS.2020.3
|
| 70 |
Wootae Kim, Joo-Won Jeong, Ja-Eun Kim. CCAR2 deficiency augments genotoxic stress-induced apoptosis in the presence of melatonin in non-small cell lung cancer cells. Tumor Biology 2014; 35(11): 10919 doi: 10.1007/s13277-014-2370-6
|
| 71 |
Karolina Jablonska, Katarzyna Nowinska, Aleksandra Piotrowska, Aleksandra Partynska, Ewa Katnik, Konrad Pawelczyk, Alicja Kmiecik, Natalia Glatzel-Plucinska, Marzenna Podhorska-Okolow, Piotr Dziegiel. Prognostic Impact of Melatonin Receptors MT1 and MT2 in Non-Small Cell Lung Cancer (NSCLC). Cancers 2019; 11(7): 1001 doi: 10.3390/cancers11071001
|
| 72 |
Busra Dincer, Gizem Yildiztekin, Irfan Cinar. Unlocking Synergistic Potential: Agomelatine Enhances the Chemotherapeutic Effect of Paclitaxel in Breast Cancer Cell Through MT1 Melatonin Receptors and ER‐alpha Axis. Chemistry & Biodiversity 2023; 20(10) doi: 10.1002/cbdv.202301093
|
| 73 |
María Antonia Cid, Alejandro Úbeda, María Luisa Hernández-Bule, María Antonia Martínez, María Ángeles Trillo. Antagonistic Effects of a 50 Hz Magnetic Field and Melatonin in the Proliferation and Differentiation of Hepatocarcinoma Cells. Cellular Physiology and Biochemistry 2012; 30(6): 1502 doi: 10.1159/000343338
|
| 74 |
Dalia Abdel-Wahab Mohamed, Hasnaa Mamdouh Abd Elazeem, Hanan Abd Al-Hameid, Reham H. Mohamed, Mohamed F. Abdel-Salam, Soha Abuelela, Asmaa A. Abozeid, Magda I. Mohamad. Low dose pterostilbene-mediated hepatic chemoprevention in diethylnitrosamine-treated rats: Modulation of Ppar alpha, Nrf2 and Capase3 expression. Gene Reports 2021; 25: 101353 doi: 10.1016/j.genrep.2021.101353
|
| 75 |
Atif Khurshid Wani, Nahid Akhtar, Sani Sharif Usman, Abdullahi Ibrahim Uba, Farida Rahayu, Taufiq Hidayat R. Side, Mala Murianingrum. Melatonin: Role in Plant Signaling, Growth and Stress Tolerance. Plant in Challenging Environments 2023; 4: 343 doi: 10.1007/978-3-031-40173-2_18
|
| 76 |
Angel Del Castillo-Vaquero, Gines M. Salido, Antonio Gonzalez. Melatonin induces calcium release from CCK-8- and thapsigargin-sensitive cytosolic stores in pancreatic AR42J cells. Journal of Pineal Research 2010; 49(3): 256 doi: 10.1111/j.1600-079X.2010.00790.x
|
| 77 |
Nikolia Αnninou, Ekaterini Chatzaki, Fotini Papachristou, Μichail Pitiakoudis, Constantinos Simopoulos. Mycotoxins’ Activity at Toxic and Sub-Toxic Concentrations: Differential Cytotoxic and Genotoxic Effects of Single and Combined Administration of Sterigmatocystin, Ochratoxin A and Citrinin on the Hepatocellular Cancer Cell Line Hep3B. International Journal of Environmental Research and Public Health 2014; 11(2): 1855 doi: 10.3390/ijerph110201855
|
| 78 |
Mariano Bizzarri, Sara Proietti, Alessandra Cucina, Russel J Reiter. Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review. Expert Opinion on Therapeutic Targets 2013; 17(12): 1483 doi: 10.1517/14728222.2013.834890
|
| 79 |
RAFAŁ JAKUB BUŁDAK, KATARZYNA PILC-GUMUŁA, ŁUKASZ BUŁDAK, DARIA WITKOWSKA, MICHAŁ KUKLA, RENATA POLANIAK, KRYSTYNA ZWIRSKA-KORCZALA. Effects of ghrelin, leptin and melatonin on the levels of reactive oxygen species, antioxidant enzyme activity and viability of the HCT 116 human colorectal carcinoma cell line. Molecular Medicine Reports 2015; 12(2): 2275 doi: 10.3892/mmr.2015.3599
|
| 80 |
Yue Gao, Xiangsheng Xiao, Changlin Zhang, Wendan Yu, Wei Guo, Zhifeng Zhang, Zhenglin Li, Xu Feng, Jiaojiao Hao, Kefang Zhang, Bingyi Xiao, Miao Chen, Wenlin Huang, Shunbin Xiong, Xiaojun Wu, Wuguo Deng. Melatonin synergizes the chemotherapeutic effect of 5‐fluorouracil in colon cancer by suppressing PI3K/AKT and NF‐κB/iNOS signaling pathways. Journal of Pineal Research 2017; 62(2) doi: 10.1111/jpi.12380
|
| 81 |
Mohammad Hossein Asghari, Emad Ghobadi, Milad Moloudizargari, Marjan Fallah, Mohammad Abdollahi. Does the use of melatonin overcome drug resistance in cancer chemotherapy?. Life Sciences 2018; 196: 143 doi: 10.1016/j.lfs.2018.01.024
|
| 82 |
Ko-Hsiu Lu, Renn-Chia Lin, Jia-Sin Yang, Wei-En Yang, Russel J. Reiter, Shun-Fa Yang. Molecular and Cellular Mechanisms of Melatonin in Osteosarcoma. Cells 2019; 8(12): 1618 doi: 10.3390/cells8121618
|
| 83 |
Wonil Koh, Soo‐Jin Jeong, Hyo‐Jung Lee, Ho‐Geon Ryu, Eun‐Ok Lee, Kyoo Seok Ahn, Hyunsu Bae, Sung‐Hoon Kim. Melatonin promotes puromycin‐induced apoptosis with activation of caspase‐3 and 5′‐adenosine monophosphate‐activated kinase‐alpha in human leukemia HL‐60 cells. Journal of Pineal Research 2011; 50(4): 367 doi: 10.1111/j.1600-079X.2010.00852.x
|
| 84 |
SILVIA CODENOTTI, MICHELA BATTISTELLI, SABRINA BURATTINI, SARA SALUCCI, ELISABETTA FALCIERI, RITA REZZANI, FIORELLA FAGGI, MARINA COLOMBI, EUGENIO MONTI, ALESSANDRO FANZANI. Melatonin decreases cell proliferation, impairs myogenic differentiation and triggers apoptotic cell death in rhabdomyosarcoma cell lines. Oncology Reports 2015; 34(1): 279 doi: 10.3892/or.2015.3987
|
| 85 |
Wamidh H. Talib. Melatonin and Cancer Hallmarks. Molecules 2018; 23(3): 518 doi: 10.3390/molecules23030518
|